Rubius Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Craig Jalbert
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO
Craig Jalbert (61 yo)
less than a year
Tenure
Mr. Craig R. Jalbert, CIRA serves as Director at Oncorus, Inc. since July 28, 2023 and serves as Chief Executive Officer, President, Chief Financial Officer, Treasurer and Secretary from August 4, 2023. He...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | less than a year | no data | no data | |
Independent Director | 8.8yrs | US$421.66k | no data | |
Member of Scientific Advisory Board | 8.8yrs | US$850.74k | no data | |
Scientific Advisory Board | 5.7yrs | US$24.00k | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
Director | 1.3yrs | no data | no data | |
Independent Director | 5.8yrs | US$426.66k | no data | |
Member of Scientific Advisory Board | 3.8yrs | US$2.84m | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data | |
Member of Scientific Advisory Board | 2.4yrs | no data | no data |
2.4yrs
Average Tenure
68yo
Average Age
Experienced Board: 5RT's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.